Advisory - Buckley's syrups recalled due to potential choking hazard
OTTAWA, March 9, 2017/CNW/ -
Issue Health Canada is advising Canadians that GlaxoSmithKline (GSK) Consumer Healthcare Inc. has initiated a voluntary recall of certain Buckley's syrup products from stores. A defect with the plastic seal may cause it to fall into the bottle and present a potential choking hazard if swallowed. This seal is a circular plastic layer that is clear or semi-transparent and approximately 1.7 cm in diameter, pictured below.
The affected products are indicated for use by adults and children above 12 years old. Buckley's Jack and Jill children's syrup is not part of the recall as it uses a different seal.
Who is affected
Consumers who have bought or used these products.
Affected products
Buckley's Complete, DIN 02279703, 150 & 250mL
Buckley's Complete Mucus Relief, DIN 02357232, 150 & 250mL
Buckley's Cough & Chest Congestion, DIN 02289164, 150 & 250mL
Buckley's Cough Mucus & Phlegm, DIN 02346451, 150 & 250mL
Buckley's Original Mixture, NPN 02239538, 100 & 200mL
Buckley's Original Mixture Night Time, DIN 02230939, 100mL
What consumers should do
According to GSK Consumer Healthcare Inc., consumers should follow the dosing instructions listed on the label. Do not drink directly from the bottle. Pour the syrup into a teaspoon and check for the plastic seal before consuming.
Consult with your health care professional if you have used these products and have health concerns.
Contact GSK Consumer Relations at 1-800-250-8866 if you have questions about this recall.
Report adverse events to health products to Health Canada by calling toll-free at 1?866?234?2345, or by reporting online, by mail or by fax.
Report complaints about health products to Health Canada by calling toll-free at 1?800?267?9675, or complete an online complaint form.
What Health Canada is doing Health Canada is monitoring the company's recall. If new safety information is identified, Health Canada will take appropriate action and inform Canadians.
For more information
Stay connected with Health Canada and receive the latest advisories and product recalls using social media tools.
To learn more about natural health products and other self-care products, visit Canada.ca/selfcare-products.
The global gastroesophageal reflux disease (GERD) market size is estimated to grow by USD 879.8 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 3.2% during the forecast period. Rising geriatric...
Pendopharm, a division of Pharmascience Inc., announced today that it has signed an exclusive distribution agreement with Ascendis Pharma A/S ("Ascendis"), a global biopharmaceutical company headquartered in Copenhagen, Denmark. Under the terms of...
Imperial Tobacco Canada Limited ("ITCAN") has officially submitted its feedback to Health Canada regarding the proposed Ministerial Order on nicotine replacement therapy products (NRTs). ITCAN strongly believes that NRTs, especially innovative...
The "Regenerative Medicine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.
Regenerative Medicine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented...
The "Diagnostic Imaging Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.
Diagnostic Imaging Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to...
King Faisal Specialist Hospital & Research Centre (KFSH&RC) has achieved a significant milestone in its Robotic Cardiac Surgery Program, which was initiated in February 2019. Within its first year, the program performed 105 cardiac procedures. As of...